KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clorox (CLX) Common Equity (2016 - 2026)

Clorox has reported Common Equity over the past 18 years, most recently at -$67.0 million for Q1 2026.

  • For Q1 2026, Common Equity fell 135.26% year-over-year to -$67.0 million; the TTM value through Mar 2026 reached -$67.0 million, down 135.26%, while the annual FY2025 figure was $482.0 million, 2.03% down from the prior year.
  • Common Equity for Q1 2026 was -$67.0 million at Clorox, down from $35.0 million in the prior quarter.
  • Over five years, Common Equity peaked at $729.0 million in Q2 2022 and troughed at -$67.0 million in Q1 2026.
  • A 5-year average of $298.3 million and a median of $224.0 million in 2024 define the central range for Common Equity.
  • Biggest five-year swings in Common Equity: soared 70.99% in 2024 and later crashed 135.26% in 2026.
  • Year by year, Common Equity stood at $491.0 million in 2022, then tumbled by 55.6% to $218.0 million in 2023, then crashed by 44.5% to $121.0 million in 2024, then crashed by 71.07% to $35.0 million in 2025, then plummeted by 291.43% to -$67.0 million in 2026.
  • Business Quant data shows Common Equity for CLX at -$67.0 million in Q1 2026, $35.0 million in Q4 2025, and $138.0 million in Q3 2025.